140 filings
Page 6 of 7
8-K
30a8rd9yc241b 3ht3o
7 Dec 18
Entry into a Material Definitive Agreement
5:15pm
8-K
m7uksqaq043ves
15 Nov 18
Akers Biosciences Announces Q3 2018 Earnings
7:00am
8-K
jmb9nb7i0dqc9c
9 Nov 18
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K/A
1ryspn57
2 Nov 18
Entry into a Material Definitive Agreement
12:15pm
8-K
b3l62fs873rjao hbu9v
31 Oct 18
Entry into a Material Definitive Agreement
9:20am
8-K
15zqu
19 Oct 18
Departure of Directors or Certain Officers
8:45am
8-K/A
lui0se9i kxj
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
8:15pm
8-K
4t0b0enfj4hp pv
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
4:30pm
8-K
ufscwycb
11 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
qg419 cloyyzfq3w9pv3
19 Jun 18
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:20pm
8-K
8p04c zaczdamler
15 Jun 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K/A
avgy9e
5 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
1b4qqjmd de
1 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
4a6hm
31 May 18
Akers Biosciences Granted 180-Day Extension by Nasdaq
8:21am
8-K
ab3el41bizjo3n14tz
25 May 18
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
5:00pm
8-K
f22hxzx6 xzz
21 May 18
Other Events
5:20pm
8-K
7c4ivsg3m9kmx3y6rfz
25 Apr 18
Departure of Directors or Certain Officers
5:27pm
8-K
7kesmx
26 Dec 17
Akers Biosciences Announces Closing of $6,900,000 Public Offering
12:00am
8-K
otui7f
19 Dec 17
Akers Biosciences Prices $6,000,000 Public Offering
12:00am
8-K
uj8mu 1yop1n1ks3
1 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am